Christopher Boone, MD
Orthopaedic Surgery · Bellevue, WANPI 1770783607
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $121,783 of the $160,495 with a category attached, or 75.9%. 24 manufacturers reported payments, led by Stryker at 57.7% of the total. Reporting peaked in 2019 at $37,202 and has fallen 87.2% since, to $4,775 in 2025. Among orthopaedic surgery clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $710.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$93K
- Surgalign Spine Technologies, Inc.$26K
- Smith+Nephew$20K
- Orthalign Inc$9K
- Arthrex$6K
- Medacta USA, Inc.$2K
- plus $4K from 18 others
Across 7 payments — averaging $728.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$3K
- Surgalign Spine Technologies, Inc.$2K
What the payments were for
- Consulting fees$121,78376%
- Speaking & faculty fees$11,9737%
- Travel & lodging$19,27712%
- Food & beverage$7,4635%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 98 | $92,679 |
| Surgalign Spine Technologies, Inc. | 7 | $25,941 |
| Smith+Nephew | 48 | $20,477 |
| Orthalign Inc | 5 | $9,194 |
| Arthrex | 11 | $5,985 |
| Medacta USA, Inc. | 16 | $2,120 |
| Zimmer Biomet | 12 | $1,636 |
| Pacira Therapeutics, Inc. | 4 | $1,316 |
| Si-bone, Inc. | 5 | $472 |
| Nuvasive Specialized Orthopedics, Inc. | 2 | $224 |
| Arteriocyte Medical Systems, Inc. | 1 | $68 |
| Bioventus LLC | 2 | $63 |
| Heraeus Medical, LLC. | 2 | $46 |
| Illuminoss Medical, Inc. | 1 | $44 |
| Pacira Pharmaceuticals Incorporated | 1 | $40 |
| Fidia Pharma USA Inc. | 2 | $37 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| Avanos Medical | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Conformis, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| Radius Health, Inc. | 1 | $14 |
| Amniox Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$56,147
- TRIATHLON$26,690
- SlMMETRY$19,850
- INSIGNIA$13,200
- NEW PRODUCT DEVELOPMENT$13,115
- RESTORATION$11,000
- TRIDENT$8,712
- GMRS$8,600
- ORTHALIGN PLUS$8,500
- Simmetry$6,063
- Journey II BCS$5,735
- Navio Surgical System$4,714
- OXINIUM Hip$4,594
- Journey Uni$4,485
- AEQUALIS$3,600
- Journey II XR$3,374
- Zilretta$1,238
- Birmingham Hip Resurfacing$1,055
- Anthology$1,055
- Persona$916
How this compares
$160,495 in reported general payments places this provider in the 90th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $9,864 |
| Pregabalin | 13 | $833 |
| Celecoxib | 26 | $506 |
| Amoxicillin | 200 | $423 |
| Gabapentin | 25 | $303 |
| Oxycodone Hcl | 44 | $274 |
| Cephalexin | 26 | $191 |
| Tramadol Hcl | 42 | $170 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $163 |
| Meloxicam | 42 | $147 |
| Cyclobenzaprine Hcl | 12 | $143 |
| Clindamycin Hcl | 34 | $119 |
| Prednisone | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bellevue
- Mathew NichollsBellevue$34K
- Ashit PatelBellevue$29K
- William BarrettRenton$7.7M
- James PritchettSeattle$6.4M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Tim LovellSpokane$1.8M
- Timothy AltonRenton$1.5M
- Burt YaszaySeattle$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.